A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences

Author:

Muls AnnORCID,Taylor Alexandra,Lalondrelle Susan,Kabir Mohammed,Norton Christine,Hart Ailsa,Andreyev H. Jervoise

Abstract

Abstract Background and aim Long-term changes in gastrointestinal function impacting quality of life after treatment for cancer are common. Peer reviewed guidance to investigate and manage GI dysfunction following cancer treatment has been published. This study reviewed gastrointestinal symptoms of women previously treated for gynaecological cancer and considered whether suggested algorithms could be amended to optimise management for this cohort. Methods Demographic and clinical data recorded for patients attending a specialist consequences of cancer treatment gastroenterology service prospectively are reported using median and range. The Wilcoxon signed rank test analysed changes in symptoms between initial assessment to discharge from the service. Results Between April 2013 and March 2016, 220 women, with a median age of 57 years (range 24–83 years), treated for gynaecological cancer (cervical (50%)), endometrial (28%), ovarian (15%), vaginal or vulval (7%) attended. Twelve gastrointestinal symptoms were statistically significantly reduced by time of discharge from the specialist gastroenterology clinic including bowel frequency ≥ 4/day (88%), type 6 or 7 stool consistency (36%), urgency (31%) and incontinence (21%). General quality of life improved from a median score of 4 at first assessment to a median of 6 at discharge (p < 0.001). A median of four (range, 1–9) diagnoses were made. Conclusion Women with gastrointestinal symptoms after cancer treatment benefit from a systematic management approach. After excluding disease recurrence, a proposed investigational algorithm and the oncology team includes FBC, U&Es, LFTs, thyroid function test, vitamin B12, vitamin D, a hydrogen methane breath test and a SeHCAT scan. If rectal bleeding is present, iron studies, flexible sigmoidoscopy or colonoscopy should be performed. Patients with normal investigations or symptoms not responding to treatment require gastroenterology input.

Funder

National Institute for Health Research

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Reference38 articles.

1. Vale C, Tierney J, Davidson S, Drinkwater KJ, Symonds P (2010) Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists’ audit. Clin Oncol (R Coll Radiol) 22:590–601. https://doi.org/10.1016/j.clon.2010.06.002

2. NHS England (2016) Guidance: implementing the Cancer Taskforce recommendations: commissioning person centred care for people affected by cancer. NHS England 2016: 17pp. Accessed August 2019 via https://www.england.nhs.uk/wp-content/uploads/2016/04/cancer-guid-v1.pdf

3. Department of Health. Living with and beyond cancer: taking action to improve outcomes. Department of Health 2013: 135pp. Accessed August 2019 via https://www.gov.uk/government/publications/living-with-and-beyond-cancer-taking-action-to-improve-outcomes

4. Andreyev HJN, Benton BE, Lalji A et al (2013) Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet 382:2084–2092

5. Muls A, Lalji A, Marshall C, Butler L, Shaw C, Vyoral S, Mohammed K, Andreyev HJ (2016) The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem? Clin Med 16(3):240–246

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3